TY - JOUR
T1 - ADAM10 mediates vascular injury induced by staphylococcus aureus α-hemolysin
AU - Powers, Michael E.
AU - Kim, Hwan Keun
AU - Wang, Yang
AU - Wardenburg, Juliane Bubeck
N1 - Funding Information:
Financial support. This work was supported by the Departments of Pediatrics and Microbiology at the University of Chicago. The authors acknowledge membership in and support from the Region V ‘‘Great Lakes’’ Regional Center of Excellence (National Institutes of Health award 2-U54-AI-057153). M. P. was partially supported by National Institutes of Health grant T32 GM007183.
PY - 2012/8/1
Y1 - 2012/8/1
N2 - Staphylococcus aureus is a leading cause of bacteremia and sepsis. The interaction of S. aureus with the endothelium is central to bloodstream infection pathophysiology yet remains ill-understood. We show herein that staphylococcal α-hemolysin, a pore-forming cytotoxin, is required for full virulence in a murine sepsis model. The α-hemolysin binding to its receptor A-disintegrin and metalloprotease 10 (ADAM10) upregulates the receptor's metalloprotease activity on endothelial cells, causing vascular endothelial-cadherin cleavage and concomitant loss of endothelial barrier function. These cellular injuries and sepsis severity can be mitigated by ADAM10 inhibition. This study therefore provides mechanistic insight into toxin-mediated endothelial injury and suggests new therapeutic approaches for staphylococcal sepsis.
AB - Staphylococcus aureus is a leading cause of bacteremia and sepsis. The interaction of S. aureus with the endothelium is central to bloodstream infection pathophysiology yet remains ill-understood. We show herein that staphylococcal α-hemolysin, a pore-forming cytotoxin, is required for full virulence in a murine sepsis model. The α-hemolysin binding to its receptor A-disintegrin and metalloprotease 10 (ADAM10) upregulates the receptor's metalloprotease activity on endothelial cells, causing vascular endothelial-cadherin cleavage and concomitant loss of endothelial barrier function. These cellular injuries and sepsis severity can be mitigated by ADAM10 inhibition. This study therefore provides mechanistic insight into toxin-mediated endothelial injury and suggests new therapeutic approaches for staphylococcal sepsis.
UR - http://www.scopus.com/inward/record.url?scp=84863922855&partnerID=8YFLogxK
U2 - 10.1093/infdis/jis192
DO - 10.1093/infdis/jis192
M3 - Article
C2 - 22474035
AN - SCOPUS:84863922855
SN - 0022-1899
VL - 206
SP - 352
EP - 356
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 3
ER -